{"SPADE_UN_23340": {"Sequence Information": {"Peptide Name": "PuroB3 [W 5,9,10 5-OH-W", "Sequence": "FRVTXRTKXXKG", "Sequence Length": 12, "Biological Activity": ["Anticancer", "Anti-Mammalian Cell"], "Binding Target": "", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "Q10464", "uniprotUrl": "http://www.uniprot.org/uniprot/Q10464", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin.", "Pubmed ID": "32126228", "Reference": "Biochim Biophys Acta. 2020;1862:183228", "Author": "Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/32126228"}], "SPADE ID": "SPADE_UN_23340", "Similar Sequences": [{"SPADE_ID": "SPADE_N_16002", "Similarity": 1.0, "Sequence": "KKCGFFCKLKNKLKSTGSRSNIAAGTHGGTFRV"}, {"SPADE_ID": "SPADE_UN_05340", "Similarity": 1.0, "Sequence": "FYWWRWFRV"}, {"SPADE_ID": "SPADE_UN_05393", "Similarity": 1.0, "Sequence": "WKIVGVFRV"}], "Hemolytic Activity": "Human erythrocytes:50% Hemolysis=>=65 µM,Human PBMC:IC50=>=65 µM", "Target Organism": "Jurkat T-cell leukemia(IC50=>=65µM)"}}}